Biomarkers in active surveillance

The use of active surveillance (AS) is increasing for favorable-risk prostate cancer. However, there remain challenges in patient selection for AS, due to the limitations of current clinical staging. In addition, monitoring protocols relying on serial biopsies is invasive and presents risks such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeb, Stacy, Tosoian, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861276/
https://www.ncbi.nlm.nih.gov/pubmed/29594029
http://dx.doi.org/10.21037/tau.2017.12.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861276/
https://www.ncbi.nlm.nih.gov/pubmed/29594029
http://dx.doi.org/10.21037/tau.2017.12.26

Ejemplares similares